Improving viral vector safety for gene therapies
Drug Discovery World
AUGUST 21, 2024
Dr Andrea O’Hara, Senior Product Manager at Azenta Life Sciences asks why integration site analysis (ISA) is critical for the safety and efficacy of viral vectors for gene therapy. The enriched DNA is then sequenced. It is recommended to consider the relative advantages and disadvantages of each approach during study design.
Let's personalize your content